NCT06871826View on ClinicalTrials.gov

Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 22, 2023

Primary Completion Date

January 25, 2025

Study Completion Date

January 25, 2025

Conditions
Acute Kidney InjuryExtracorporeal Circulation; ComplicationsSurgery
Interventions
DRUG

TIMP2 level

different TIMP2 level after on-pump cardiac surgery

Trial Locations (1)

430061

Zhongnan Hospital, Wuhan

All Listed Sponsors
lead

Wuhan University

OTHER

NCT06871826 - Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter